Conjugate Vaccine Market Research, Trends, Outlook and Forecast Analysis to 2023
A research report on “Global Conjugate Vaccine Market (2018-2023)” has been recently produced by Kay Dee Market Insights. The report is categorized in different parts, such as market dynamics, market sizing, competitive analysis and more. Different analytical methods such as Porter’s analysis, PEST analysis and more have been used to get a 360° analysis of the global Conjugate Vaccine market. In a competitive landscape part, KD Market Insights has focused on company profiling, market positioning, market share analysis and more.
Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. The global conjugate vaccine market is expected to grow at a CAGR of 14.6%, leading to global revenue of USD 100.59 Bn by 2023. By volume, it is anticipated to reach 9600.56 Million units by 2023, expanding at a CAGR of 17.2%.
Request for Sample @ https://www.kdmarketinsights.com/sample/3225
The conjugate vaccine market is classified into two primary segments-based on disease indication: pneumococcal, Haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others; and based on end-user: pediatric and adult. Asia-Pacific will have the highest CAGR during the forecasted period.
Key growth factors:
- Rising adoption of cancer therapeutic vaccines, improvement in patient compliance along with an increasing product pipeline, and growing efforts for the adoption of appropriate preventive screening methods to help avert adverse reactions will accelerate the market.
- Conjugate Vaccine market is expected to have positive growth owing to technological advancements, growth initiatives for the production of low-cost vaccines, and widespread routine vaccination programs in emerging economies.
Threats and key players:
- Although the conjugate vaccine market is expected to have a positive growth globally, lack of awareness, shortage risk, the situation of oligopoly, uncertainty about the future of international initiatives, emerging manufacturers, and costs and prices of new vaccines will hinder growth.
- Major Conjugate Vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Sanofi Pasteur, Novartis, etc.
What’s covered in the report?
1. Overview of the global conjugate vaccine market
2. Market drivers and challenges in the global conjugate vaccine market
3. Market trends in the global conjugate vaccine market
4. Historical, current and forecasted market size data for the global disease indication segment (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for the global end user segment (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Historical, current and forecasted regional (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) market size data for the conjugate vaccine market – by revenue and by volume
7. Historical, current and forecasted market size data for the region-wise conjugate vaccine market segments – by revenue and by volume
8. Analysis of the competitive landscape and profiles of major companies operating in the market
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary – II
Chapter 2: Market overview
2.1. Market definitions
2.2. Global market overview – by revenue
- Global historical (2015-2017) market revenue (USD Bn)
- Global forecasted (2018-2023) market revenue (USD Bn)
- Geography-wise market (2018-2023) revenue (USD Bn)
2.3. Global market overview – by volume
- Global historical (2015-2017) market volume (Million units)
- Global forecasted (2018-2023) market volume (Million units)
- Geography-wise (2018-2023) market volume (Million units)
2.4. Global market drivers and challenges
2.4.1. Global market drivers
2.4.2. Global market challenges
2.5. Global market trends
2.6. Value chain
2.7.1. Regional market overview - North America
- Observation
- Key competitors
2.7.1(A) Regional market overview – North America by revenue and by volume
- North America historical (2015-2017) market revenue (USD Bn)
- North America forecasted (2018-2023) market revenue (USD Bn)
- North America historical (2015-2017) market volume (Million units)
- North America forecasted (2018-2023) market volume (Million units)
2.7.2. Regional market overview – Europe
- Observation
- Key competitors
2.7.2(A) Regional market overview – Europe by revenue and by volume
- Europe historical (2015-2017) market revenue (USD Bn)
- Europe forecasted (2018-2023) market revenue (USD Bn)
- Europe historical (2015-2017) market volume (Million units)
- Europe forecasted (2018-2023) market volume (Million units)
2.7.3. Regional market overview – Asia-Pacific
- Observation
- Key competitors
2.7.3(A) Regional market overview – Asia Pacific by revenue and by volume
- Asia Pacific historical (2015-2017) market revenue (USD Bn)
- Asia Pacific forecasted (2018-2023) market revenue (USD Bn)
- Asia Pacific historical (2015-2017) market volume (Million units)
- Asia Pacific forecasted (2018-2023) market volume (Million units)
2.7.4. Regional market overview – Latin America
- Observation
- Key competitors
2.7.4(A) Regional Market Overview – Latin America by revenue and by volume
- Latin America historical (2015-2017) market revenue (USD Bn)
- Latin America forecasted (2018-2023) market revenue (USD Bn)
- Latin America historical (2015-2017) market volume (Million units)
- Latin America forecasted (2018-2023) market volume (Million units)
2.7.5. Regional market overview – Middle East & Africa
- Observation
- Key competitors
2.7.5(A) Regional market overview – Middle East & Africa by revenue and by volume
- Middle East & Africa historical (2015-2017) market revenue (USD Bn)
- Middle East & Africa forecasted (2018-2023) market revenue (USD Bn)
- Middle East & Africa historical (2015-2017) market volume (Million units)
- Middle East & Africa forecasted (2018-2023) market volume (Million units)
Chapter 3: Major segment overview - global by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Pneumococcal – global volume (Million units)
- Market share (2015, 2018 & 2023): Hib – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Hib – global volume (Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): DTP – global volume (Million units)
- Market share (2015, 2018 & 2023): Meningococcal – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Meningococcal – global volume (Million units)
Chapter 4: Major segment overview - global by end-user
4.1. End-user: Pediatric, Adult - by revenue, by volume, CAGR
- Overview - by end-user
- Market share (2015, 2018 & 2023): Paediatric – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Paediatric – global volume (Million units)
- Market share (2015, 2018 & 2023): Adult – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Adult – global volume (Million units)
Chapter 5: North America – by disease indication
5.1. North America: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.2. North America: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.3. North America: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.4. North America: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 6: North America – by end user
6.1. North America: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 7: Europe – by disease indication
7.1. Europe: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.2. Europe: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.3. Europe: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.4. Europe: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 8: Europe – by end-user
8.1. Europe: end-user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 9: Asia Pacific – by disease indication
9.1. Asia Pacific: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.2. Asia Pacific: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.3. Asia Pacific: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.4. Asia Pacific: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 10: Asia Pacific – by end-user
10.1. Asia Pacific: end-user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 11: Latin America - by disease indication
11.1. Latin America: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.2. Latin America: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.3. Latin America: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.4. Latin America: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 12: Latin America - by end user
12.1. Latin America: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 13: Middle East & Africa - by disease indication
13.1. Middle East & Africa: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
13.2. Middle East & Africa: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
13.3. Middle East & Africa: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
13.4. Middle East & Africa: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 14: Middle East & Africa - by end user
14.1. Middle East & Africa: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Continue…
Get Exclusive Discount on This Report: @ https://www.kdmarketinsights.com/discount/3225
About Us:
KD Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends. Our in-house research experts have a wealth of knowledge in their respective domains. With KD Market Insights, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.
Our client's list includes various Fortune 500 companies and leading advisory firms.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
Read More News- https://medium.com/@sanjeevpatel.sk
Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. The global conjugate vaccine market is expected to grow at a CAGR of 14.6%, leading to global revenue of USD 100.59 Bn by 2023. By volume, it is anticipated to reach 9600.56 Million units by 2023, expanding at a CAGR of 17.2%.
Request for Sample @ https://www.kdmarketinsights.com/sample/3225
The conjugate vaccine market is classified into two primary segments-based on disease indication: pneumococcal, Haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others; and based on end-user: pediatric and adult. Asia-Pacific will have the highest CAGR during the forecasted period.
Key growth factors:
- Rising adoption of cancer therapeutic vaccines, improvement in patient compliance along with an increasing product pipeline, and growing efforts for the adoption of appropriate preventive screening methods to help avert adverse reactions will accelerate the market.
- Conjugate Vaccine market is expected to have positive growth owing to technological advancements, growth initiatives for the production of low-cost vaccines, and widespread routine vaccination programs in emerging economies.
Threats and key players:
- Although the conjugate vaccine market is expected to have a positive growth globally, lack of awareness, shortage risk, the situation of oligopoly, uncertainty about the future of international initiatives, emerging manufacturers, and costs and prices of new vaccines will hinder growth.
- Major Conjugate Vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Sanofi Pasteur, Novartis, etc.
What’s covered in the report?
1. Overview of the global conjugate vaccine market
2. Market drivers and challenges in the global conjugate vaccine market
3. Market trends in the global conjugate vaccine market
4. Historical, current and forecasted market size data for the global disease indication segment (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for the global end user segment (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Historical, current and forecasted regional (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) market size data for the conjugate vaccine market – by revenue and by volume
7. Historical, current and forecasted market size data for the region-wise conjugate vaccine market segments – by revenue and by volume
8. Analysis of the competitive landscape and profiles of major companies operating in the market
Get the Complete Research Report with TOC @:
Conjugate Vaccine Market
Table of Contents:Conjugate Vaccine Market
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary – II
Chapter 2: Market overview
2.1. Market definitions
2.2. Global market overview – by revenue
- Global historical (2015-2017) market revenue (USD Bn)
- Global forecasted (2018-2023) market revenue (USD Bn)
- Geography-wise market (2018-2023) revenue (USD Bn)
2.3. Global market overview – by volume
- Global historical (2015-2017) market volume (Million units)
- Global forecasted (2018-2023) market volume (Million units)
- Geography-wise (2018-2023) market volume (Million units)
2.4. Global market drivers and challenges
2.4.1. Global market drivers
2.4.2. Global market challenges
2.5. Global market trends
2.6. Value chain
2.7.1. Regional market overview - North America
- Observation
- Key competitors
2.7.1(A) Regional market overview – North America by revenue and by volume
- North America historical (2015-2017) market revenue (USD Bn)
- North America forecasted (2018-2023) market revenue (USD Bn)
- North America historical (2015-2017) market volume (Million units)
- North America forecasted (2018-2023) market volume (Million units)
2.7.2. Regional market overview – Europe
- Observation
- Key competitors
2.7.2(A) Regional market overview – Europe by revenue and by volume
- Europe historical (2015-2017) market revenue (USD Bn)
- Europe forecasted (2018-2023) market revenue (USD Bn)
- Europe historical (2015-2017) market volume (Million units)
- Europe forecasted (2018-2023) market volume (Million units)
2.7.3. Regional market overview – Asia-Pacific
- Observation
- Key competitors
2.7.3(A) Regional market overview – Asia Pacific by revenue and by volume
- Asia Pacific historical (2015-2017) market revenue (USD Bn)
- Asia Pacific forecasted (2018-2023) market revenue (USD Bn)
- Asia Pacific historical (2015-2017) market volume (Million units)
- Asia Pacific forecasted (2018-2023) market volume (Million units)
2.7.4. Regional market overview – Latin America
- Observation
- Key competitors
2.7.4(A) Regional Market Overview – Latin America by revenue and by volume
- Latin America historical (2015-2017) market revenue (USD Bn)
- Latin America forecasted (2018-2023) market revenue (USD Bn)
- Latin America historical (2015-2017) market volume (Million units)
- Latin America forecasted (2018-2023) market volume (Million units)
2.7.5. Regional market overview – Middle East & Africa
- Observation
- Key competitors
2.7.5(A) Regional market overview – Middle East & Africa by revenue and by volume
- Middle East & Africa historical (2015-2017) market revenue (USD Bn)
- Middle East & Africa forecasted (2018-2023) market revenue (USD Bn)
- Middle East & Africa historical (2015-2017) market volume (Million units)
- Middle East & Africa forecasted (2018-2023) market volume (Million units)
Chapter 3: Major segment overview - global by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Pneumococcal – global volume (Million units)
- Market share (2015, 2018 & 2023): Hib – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Hib – global volume (Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): DTP – global volume (Million units)
- Market share (2015, 2018 & 2023): Meningococcal – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Meningococcal – global volume (Million units)
Chapter 4: Major segment overview - global by end-user
4.1. End-user: Pediatric, Adult - by revenue, by volume, CAGR
- Overview - by end-user
- Market share (2015, 2018 & 2023): Paediatric – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Paediatric – global volume (Million units)
- Market share (2015, 2018 & 2023): Adult – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Adult – global volume (Million units)
Chapter 5: North America – by disease indication
5.1. North America: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.2. North America: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.3. North America: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.4. North America: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 6: North America – by end user
6.1. North America: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 7: Europe – by disease indication
7.1. Europe: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.2. Europe: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.3. Europe: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.4. Europe: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 8: Europe – by end-user
8.1. Europe: end-user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 9: Asia Pacific – by disease indication
9.1. Asia Pacific: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.2. Asia Pacific: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.3. Asia Pacific: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.4. Asia Pacific: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 10: Asia Pacific – by end-user
10.1. Asia Pacific: end-user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 11: Latin America - by disease indication
11.1. Latin America: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.2. Latin America: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.3. Latin America: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.4. Latin America: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 12: Latin America - by end user
12.1. Latin America: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 13: Middle East & Africa - by disease indication
13.1. Middle East & Africa: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
13.2. Middle East & Africa: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
13.3. Middle East & Africa: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
13.4. Middle East & Africa: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 14: Middle East & Africa - by end user
14.1. Middle East & Africa: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Continue…
Get Exclusive Discount on This Report: @ https://www.kdmarketinsights.com/discount/3225
About Us:
KD Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends. Our in-house research experts have a wealth of knowledge in their respective domains. With KD Market Insights, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.
Our client's list includes various Fortune 500 companies and leading advisory firms.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
Read More News- https://medium.com/@sanjeevpatel.sk
Comments
Post a Comment